vimarsana.com

Page 2 - கடுமையான பயோடெக் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Merck s Welireg scores FDA nod in cancers spurred by rare disease—and its label is broader than expected

Belzutifan, now sold as Welireg, snared its first FDA approval on Friday for patients with a number of cancers associated with the rare disorder known as von Hippel-Lindau disease. The agency’s decision comes a month ahead of its expected decision date, and its label is broader than what some analysts expected.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.